HealthEquity (NASDAQ:HQY) Issues Earnings Results, Beats Estimates By $0.05 EPS

HealthEquity (NASDAQ:HQY) issued its earnings results on Thursday. The company reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $1.19 by $0.05, FiscalAI reports. The business had revenue of $350.73 million for the quarter, compared to the consensus estimate of $349.22 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%.

HealthEquity Trading Down 0.9%

HQY opened at $104.42 on Thursday. HealthEquity has a twelve month low of $72.76 and a twelve month high of $107.62. The company has a 50-day simple moving average of $97.77 and a 200 day simple moving average of $87.71. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $8.73 billion, a price-to-earnings ratio of 39.11, a P/E/G ratio of 1.77 and a beta of 0.21.

Analyst Ratings Changes

A number of research firms recently commented on HQY. Weiss Ratings upgraded HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, June 5th. Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday, August 22nd. BTIG Research raised their price target on HealthEquity from $110.00 to $115.00 and gave the company a “buy” rating in a report on Friday, July 24th. Wells Fargo & Company set a $111.00 price objective on shares of HealthEquity in a report on Monday, June 1st. Finally, Barrington Research restated an “outperform” rating and set a $110.00 target price on shares of HealthEquity in a research note on Friday, May 22nd. Eleven investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $110.93.

Insider Buying and Selling

In other HealthEquity news, EVP Michael Henry Fiore sold 3,142 shares of the firm’s stock in a transaction dated Friday, May 29th. The shares were sold at an average price of $95.00, for a total value of $298,490.00. Following the transaction, the executive vice president directly owned 59,113 shares of the company’s stock, valued at $5,615,735. This trade represents a 5.05% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 7,966 shares of company stock valued at $756,770. 1.60% of the stock is owned by company insiders.

Institutional Trading of HealthEquity

Several large investors have recently made changes to their positions in the company. Sivia Capital Partners LLC bought a new position in HealthEquity in the 2nd quarter valued at approximately $306,000. Kemnay Advisory Services Inc. bought a new stake in shares of HealthEquity during the fourth quarter worth $94,000. Johnson Investment Counsel Inc. bought a new stake in shares of HealthEquity during the fourth quarter worth $212,000. Smartleaf Asset Management LLC grew its stake in shares of HealthEquity by 51.9% during the fourth quarter. Smartleaf Asset Management LLC now owns 793 shares of the company’s stock worth $73,000 after buying an additional 271 shares during the last quarter. Finally, Parallel Advisors LLC increased its holdings in shares of HealthEquity by 14.3% during the fourth quarter. Parallel Advisors LLC now owns 1,387 shares of the company’s stock worth $127,000 after buying an additional 173 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.